Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

4.7K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.7K
Bone Remodeling01:40

Bone Remodeling

41.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
41.1K
Bone Remodeling and Repair01:31

Bone Remodeling and Repair

9.4K
9.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring the impact of nucleotide length on lipid nanoparticle structure and properties.

International journal of pharmaceutics·2026
Same author

Recapitulating the Native Tendon Environment in a Synthetic 3D Anisotropic Hydrogel as an Engineered Extracellular Matrix.

ACS applied bio materials·2026
Same author

Reproducible 3D bioprinting of <i>Streptococcus mutans</i> to create model oral biofilms.

Microbiology spectrum·2025
Same author

Salivary gland tissue chip screening identifies candidate radioprotective drugs.

Communications medicine·2025
Same author

Structure-reactivity based control of radical-mediated degradation in thiol-Michael hydrogels.

Journal of materials chemistry. B·2025
Same author

Dose-dependent osteoimmunomodulatory effects of amorphous calcium phosphate nanoparticles promote 3D-printed scaffold-mediated bone regeneration.

Bioactive materials·2025
Same journal

Anomalous Hall effect in room-temperature two-dimensional van der Waals ferromagnets.

Nanoscale horizons·2026
Same journal

Light-induced acceleration of specific binding between CEACAM-5 and antibodies for early detection of colorectal cancer.

Nanoscale horizons·2026
Same journal

Study on the anti-inflammatory effect of tetrahedral framework nucleic acid-loaded sinomenine in the treatment of rheumatoid arthritis.

Nanoscale horizons·2026
Same journal

Enhancing photodynamic and chemodynamic therapy efficacy through a novel ROS-amplifying therapeutic platform for breast cancer treatment.

Nanoscale horizons·2026
Same journal

Acacetin-incorporated lipid nanoparticles for inhaled mRNA vaccines.

Nanoscale horizons·2026
Same journal

Nanofluidic systems for ionic intelligence.

Nanoscale horizons·2026
See all related articles

Related Experiment Video

Updated: Mar 31, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.2K

Regenerative bone-targeted nanoparticles modulate osteoclast function.

Vignesh K Rangasami1, Cameron J Moore1, Baixue Xiao2,3

  • 1Department of Bioengineering, Phil and Penny Knight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, OR, USA. dbenoit@uoregon.edu.

Nanoscale Horizons
|March 30, 2026
PubMed
Summary
This summary is machine-generated.

This study shows that a novel nanoparticle drug delivery system (TBP-NPAR28) inhibits osteoclast activity, reducing bone resorption and promoting fracture healing. This dual action offers new therapeutic strategies for bone diseases.

More Related Videos

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

7.7K
Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

25.1K

Related Experiment Videos

Last Updated: Mar 31, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.2K
A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
07:03

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro

Published on: June 16, 2022

7.7K
Osteoclast Derivation from Mouse Bone Marrow
06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

25.1K

Area of Science:

  • Biomaterials Science
  • Orthopedics
  • Cell Biology

Background:

  • Osteoclasts are critical for bone remodeling, but their dysregulation contributes to bone diseases like osteoporosis and impaired fracture healing.
  • Current biomaterial strategies to modulate osteoclast activity for bone regeneration are limited.
  • A previously developed drug delivery system (DDS) using TRAP binding peptide (TBP)-functionalized nanoparticles loaded with AR28 (TBP-NPAR28) enhanced fracture healing through macrophage polarization and osteogenic differentiation.

Purpose of the Study:

  • To investigate the impact of TBP-NPAR28 on osteoclastogenesis and function.
  • To evaluate the potential of TBP-NPAR28 as a therapeutic strategy for bone regeneration by modulating osteoclast activity.

Main Methods:

  • Murine bone marrow-derived osteoclasts were treated with TBP-NPAR28.
  • Osteoclastogenesis was assessed by gene expression analysis of key osteoclast markers (NFATc, cFOS, CTSK).
  • Osteoclast function was evaluated by measuring bone resorption capacity.

Main Results:

  • TBP-NPAR28 treatment significantly decreased osteoclastogenesis.
  • Key osteoclast genes (NFATc, cFOS, CTSK) were downregulated in treated osteoclasts.
  • Osteoclast bone resorption capacity was significantly reduced.

Conclusions:

  • TBP-NPAR28 effectively inhibits osteoclastogenesis and function.
  • This inhibition, combined with previously observed pro-regenerative effects, positions TBP-NPAR28 as a promising therapeutic for enhancing bone regeneration.
  • The findings suggest new strategies for treating bone diseases characterized by disrupted bone homeostasis.